Shares of CVS Health dropped 10% in premarket trading. The drugstore chain expects 2024 adjusted earnings of at least $7 per share. Analysts surveyed by LSEG were expecting full-year adjusted profit. CVS also cut its unadjusted earnings guidance to at least $5.64.